Position in NVO
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$489,659
-$34,202 QoQ
Shares Held
10,214
+34.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#720
of 1,348 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hudock, Inc. holds $16,088,795 across 11 Drug Manufacturers - General names. NVO ranks #7 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
31,152 | $4,003,032 | |
| 2 | LLY |
ELI LILLY & Co
|
3,005 | $3,604,287 | |
| 3 | JNJ |
Johnson & Johnson
|
13,164 | $3,343,261 | |
| 4 | AMGN |
Amgen Inc
|
5,733 | $2,076,033 | |
| 5 | PFE |
Pfizer Inc
|
33,067 | $796,253 | |
| 6 | ABBV |
AbbVie Inc.
|
2,303 | $579,526 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
10,214 | $489,659 | |
| 8 | AZN |
Astrazeneca PLC
|
1,838 | $348,521 |
All Filings in NVO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $489,659 | 10,214 | Shares | Sole | 2026-07-31 | |
| 2025-06-30 | $523,861 | 7,590 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $536,840 | 7,731 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $456,594 | 5,308 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $305,414 | 2,565 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $469,900 | 3,292 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $414,475 | 3,228 | Shares | Sole | 2024-05-02 | |
| No filing history on record for this holder in this stock. | ||||||